Skip to main content
. 2019 Apr 24;8(9):e011013. doi: 10.1161/JAHA.118.011013

Table 1.

Characteristics of AASK Cohort Study Participants Included for Analysis by Categories of Difference Between Clinic and Awake SBP

Characteristics Clinic BP–Mean Awake ABP, mm Hg
White‐Coat Effect Reference Masked Effect
≥10 5 to <10 0 to <5 −5 to <0 ≥−5
(N=93) (N=56) (N=70) (N=97) (N=294)
Age, y 60.4±9.3 61.2±8.4 59.5±10.9 58.5±9.7 60.1±10.6
Female sex 43 (46.2) 33 (58.9) 29 (41.4) 36 (37.1) 92 (31.3)
Heart disease 35 (35) 34 (61) 56 (58) 65 (70) 197 (67)
eGFR, mL/min per 1.73 m2 39.9±16.5 36.3±15.0 35.9±15.2 42.7±16.3 39.2±15.2
Proteinuria, median (IQR), g/ga 0.05 (0.02–0.1) 0.09 (0.04–0.34) 0.07 (0.03–0.26) 0.05 (0.03–0.29) 0.06 (0.03–0.32)
Randomized to strict BP control during the AASK Cohort Study 49 (52.7) 30 (53.6) 30 (42.9) 48 (49.5) 147 (50.0)

Data are given as mean±SD or number (percentage), unless otherwise indicated. AASK indicates African American Study of Kidney Disease and Hypertension; ABP, ambulatory BP; BP, blood pressure; eGFR, estimated glomerular filtration rate; IQR, interquartile range; SBP, systolic BP.

a

Missing in N=81.